image
Healthcare - Biotechnology - NASDAQ - US
$ 2.75
-3.85 %
$ 211 M
Market Cap
-6.25
P/E
BALANCE SHEET
89.4 M ASSETS
-27.32%
6.86 M LIABILITIES
-55.93%
82.5 M EQUITY
-23.18%
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition Trevi Therapeutics, Inc.
image
Current Assets 87.5 M
Cash & Short-Term Investments 83 M
Receivables 0
Other Current Assets 4.58 M
Non-Current Assets 1.86 M
Long-Term Investments 0
PP&E 1.56 M
Other Non-Current Assets 297 K
Current Liabilities 5.82 M
Accounts Payable 1.81 M
Short-Term Debt 612 K
Other Current Liabilities 3.4 M
Non-Current Liabilities 1.03 M
Long-Term Debt 1.03 M
Other Non-Current Liabilities 0

Balance Sheet

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016
ASSETS
Cash & Cash Equivalents 32.4 12.6 36.8 45.0 57.3 17.2 22.0 8.3
Short Term Investments 50.6 107.9 0 0 0 0 0 0
Receivables 0 0 0 0.3 0.6 0.2 0 0
Inventory 0 0 0 0.9 1.6 1.4 63 K 0
Other Current Assets 4.6 2.1 0.9 1.0 1.7 1.4 0.1 0.1
Total Current Assets 87.5 122.6 38.0 46.3 59.6 18.8 22.2 8.4
PP&E 1.6 0.2 0.2 0.3 0.4 0.1 14 K 5 K
Intangible Assets 0 0 0 0 0 0 0 0
Goodwill 0 0 0 0 0 0 0 0
Long Term Investments 0 0 0 0 0 0 0 0
Other Long Term Assets 0.3 0.2 0.3 0.5 19 K 1.6 52 K 12 K
Other Assets 0 0 0 0 0 0 0 0
Total Assets 89.4 123.0 38.5 47.1 60.0 20.5 22.2 8.4
LIABILITIES
Accounts Payable 1.8 2.9 2.8 2.0 1.6 0.6 0.5 0.4
Short Term Debt 0.6 7.0 6.0 0.2 0.2 0 5.3 17.0
Other Current Liabilities 3.4 3.5 3.9 3.3 3.4 2.1 1.3 3.0
Total Current Liabilities 5.8 13.4 12.7 5.6 5.2 2.7 7.1 20.4
Long Term Debt 1.0 2.2 8.7 14.1 0.3 1.1 0 5.1
Deferred Tax Income 0 0 0 0 0 0 0 0
Other Liabilities 0 3 K 0 0.2 0 0.5 0.3 0.3
Total Liabilities 6.9 15.6 21.4 19.8 5.5 3.2 7.5 25.8
EQUITY
Common Stock 68 K 60 K 29 K 19 K 18 K 0.1 4 K 4 K
Retained Earnings (239.1) (210.1) (180.9) (147.0) (114.2) (109.5) (84.4) (72.2)
Other Accumulative Comprehensive Income/Loss 29 K (0.1) 0 0 (60.0) 46 K 23 K 0
Total Equity 82.5 107.5 17.1 27.3 54.5 17.3 14.8 (17.4)
Total Liabilities and Equity 89.4 123.0 38.5 47.1 60.0 20.5 22.2 8.4
SHARES OUTSTANDING
Common Shares Outstanding 99.0 64.5 22.8 18.1 11.7 9.0 9.0 16.1